Charles Morris

Charles Morris

Teknisk/Vetenskaplig/F&U Direktör på PRELUDE THERAPEUTICS INCORPORATED
61 år
Health Technology
Consumer Services

Profil

Charles Q.
Morris
is currently a Member at The Royal College of Physicians and Chief Medical Officer at Prelude Therapeutics, Inc. starting in 2026.
Former positions include Vice President-Worldwide Clinical Research at Cephalon, Inc., Chief Development Officer & Executive VP at ImmunoGen, Inc. from 2012 to 2016, Chief Medical Officer & Executive Vice President at Allos Therapeutics, Inc. from 2010 to 2012, Chief Medical Officer at Radius Health, Inc. from 2018 to 2020, Vice President-Clinical Development Projects at AstraZeneca Pharmaceuticals LP, Chief Development Officer at Akamis Bio Ltd. from 2016 to 2018, and Chief Medical Officer at Celyad Oncology SA from 2021 to 2023.
Education includes undergraduate studies at the University of Sheffield Medical School.

Aktiva positioner av Charles Morris

FöretagPositionStart
PRELUDE THERAPEUTICS INCORPORATED Teknisk/Vetenskaplig/F&U Direktör 2026-04-20
Företagsledare/Principal 2010-07-09

Tidigare kända positioner av Charles Morris

FöretagPositionSlut
LAVA THERAPEUTICS Teknisk/Vetenskaplig/F&U Direktör 2025-10-01
CELYAD ONCOLOGY SA Teknisk/Vetenskaplig/F&U Direktör 2023-01-01
RADIUS HEALTH, INC. Teknisk/Vetenskaplig/F&U Direktör 2020-12-15
Företagsledare/Principal 2018-09-01
IMMUNOGEN, INC. Företagsledare/Principal 2016-09-02
Se detaljerna i Charles Morriss erfarenhet

Charles Morriss utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

63

Första gradens relationer

11

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag11

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

  1. Börsen
  2. Insiders
  3. Charles Morris